Skip to main content
. 2018 Jul 5;13:2089–2099. doi: 10.2147/COPD.S164259

Figure 1.

Figure 1

Algorithm for withdrawal of ICS in symptomatic patients with COPD.a

Note: aIf asthma–COPD overlap, continue ICS therapy and monitor for potential ICS-related adverse events; percentages of patients are based on the DACCORD population.55

Abbreviations: ICS, inhaled corticosteroid; LABA, long-acting β2-adrenoreceptor agonists; LAMA, long-acting muscarinic receptor antagonist.